Myriad Genetics Inc (NASDAQ:MYGN)

28.52
Delayed Data
As of 4:00pm ET
 +0.02 / +0.07%
Today’s Change
22.04
Today|||52-Week Range
48.77
-1.89%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Capone Mark C
President & Chief Executive Officer
Sale8/01/201970,672$44.00$3.1M-36.68%
Capone Mark C
President & Chief Executive Officer
Sale8/01/201958,138$44.00$2.6M-36.68%
Capone Mark C
President & Chief Executive Officer
Buy8/01/201958,138$30.34$1.8M-36.68%
Capone Mark C
President & Chief Executive Officer
Buy8/01/201970,672$23.11$1.6M-36.68%
King Gary A /myriad/
Executive Vice President
Sale8/01/201930,000$46.19$1.4M-36.68%
Riggsbee R Bryan
Chief Financial Officer
Sale8/01/201925,000$41.50$1.0M-36.68%
Capone Mark C
President & Chief Executive Officer
Sale9/25/201818,295$46.65$853.5K-38.91%
Capone Mark C
President & Chief Executive Officer
Sale9/30/201818,295$46.00$841.6K-36.16%
King Gary A /myriad/
Executive Vice President
Buy8/01/201930,000$26.49$794.7K-36.68%
King Gary A /myriad/
Executive Vice President
Sale8/01/201920,000$39.44$788.8K-36.68%
Page of 8